Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001615219-16-000137
Filing Date
2016-03-18
Accepted
2016-03-18 17:04:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 flks-20160318sx3.htm S-3 424570
2 EXHIBIT 4.6 flks20160318ex-46.htm EX-4.6 434363
3 EXHIBIT 4.8 flks20160318ex-48.htm EX-4.8 148641
4 EXHIBIT 4.9 flks20160318ex-49.htm EX-4.9 146670
5 EXHIBIT 4.10 flks20160318ex-410.htm EX-4.10 130155
6 EXHIBIT 5.1 flks20160318ex-51.htm EX-5.1 34619
7 EXHIBIT 12.1 flks20160318ex-121.htm EX-12.1 21755
8 EXHIBIT 23.1 flks20160318ex-231.htm EX-23.1 2527
9 flexpha_image1a01.jpg GRAPHIC 10112
10 flkss3shelfregistrati_image1.jpg GRAPHIC 17489
  Complete submission text file 0001615219-16-000137.txt   1382479
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-210289 | Film No.: 161516786
SIC: 2834 Pharmaceutical Preparations